BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16003667)

  • 1. Predictors of prescriptions for management of fatigue among veterans with multiple sclerosis.
    Hatzakis M; Turner AP; Williams RM; Bowen JD; Rodriquez AA; Haselkorn JK
    Arch Phys Med Rehabil; 2005 Jul; 86(7):1376-80. PubMed ID: 16003667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
    Nourbakhsh B; Revirajan N; Waubant E
    Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue in multiple sclerosis: an overview of assessment and pharmacologic treatment.
    Dunmore FR
    Adv NPs PAs; 2013 Apr; 4(4):23-5, 32. PubMed ID: 23599993
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
    Brañas P; Jordan R; Fry-Smith A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(27):1-61. PubMed ID: 11074395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disability and treatment patterns of multiple sclerosis patients in United States: a comparison of veterans and nonveterans.
    Vollmer TL; Hadjimichael O; Preiningerova J; Ni W; Buenconsejo J
    J Rehabil Res Dev; 2002; 39(2):163-74. PubMed ID: 12051461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking among veterans with multiple sclerosis: prevalence correlates, quit attempts, and unmet need for services.
    Turner AP; Kivlahan DR; Kazis LE; Haselkorn JK
    Arch Phys Med Rehabil; 2007 Nov; 88(11):1394-9. PubMed ID: 17964878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
    Yang TT; Wang L; Deng XY; Yu G
    J Neurol Sci; 2017 Sep; 380():256-261. PubMed ID: 28870581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohorts.
    Culpepper WJ; Wallin MT; Magder LS; Perencevich E; Royal W; Bradham DD; Cutter G; Bever CT
    J Rehabil Res Dev; 2015; 52(3):263-72. PubMed ID: 26220064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating fatigue in patients with MS: one step forward, one step back.
    Schwid SR; Murray TJ
    Neurology; 2005 Apr; 64(7):1111-2. PubMed ID: 15824329
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of fatigue in patients with multiple sclerosis.
    Zifko UA
    Drugs; 2004; 64(12):1295-304. PubMed ID: 15200345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Risk of Chronic Multisymptom Illness in Spouses of Gulf War Era Veterans.
    Blanchard M; Toomey R; Karlinsky J; Reda D; Alpern R; Xue L
    Mil Med; 2017 May; 182(5):e1648-e1656. PubMed ID: 29087907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol misuse and multiple sclerosis.
    Turner AP; Hawkins EJ; Haselkorn JK; Kivlahan DR
    Arch Phys Med Rehabil; 2009 May; 90(5):842-8. PubMed ID: 19406306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating fatigue.
    Lapierre Y; Hum S
    Int MS J; 2007 Jun; 14(2):64-71. PubMed ID: 17686346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderators of Treatment Outcomes After Telehealth Self-Management and Education in Adults With Multiple Sclerosis: A Secondary Analysis of a Randomized Controlled Trial.
    Ehde DM; Arewasikporn A; Alschuler KN; Hughes AJ; Turner AP
    Arch Phys Med Rehabil; 2018 Jul; 99(7):1265-1272. PubMed ID: 29337024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Suboptimal Medication Adherence in Persons With Multiple Sclerosis: Development of an Electronic Health Record-Based Explanatory Model for Disease-Modifying Therapy Use.
    Gromisch ES; Turner AP; Leipertz SL; Beauvais J; Haselkorn JK
    Arch Phys Med Rehabil; 2020 May; 101(5):807-814. PubMed ID: 31809751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management options in multiple sclerosis-associated fatigue.
    Amato MP; Portaccio E
    Expert Opin Pharmacother; 2012 Feb; 13(2):207-16. PubMed ID: 22220738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS).
    Benito-León J; Martínez-Martín P; Frades B; Martínez-Ginés ML; de Andrés C; Meca-Lallana JE; Antigüedad AR; Huete-Antón B; Rodríguez-García E; Ruiz-Martínez J
    Mult Scler; 2007 Jun; 13(5):645-51. PubMed ID: 17548445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amantadine for fatigue in multiple sclerosis.
    Taus C; Giuliani G; Pucci E; D'Amico R; Solari A
    Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise and quality of life among people with multiple sclerosis: looking beyond physical functioning to mental health and participation in life.
    Turner AP; Kivlahan DR; Haselkorn JK
    Arch Phys Med Rehabil; 2009 Mar; 90(3):420-8. PubMed ID: 19254606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of fractures in a cohort of veterans with chronic multiple sclerosis or traumatic spinal cord injury.
    Logan WC; Sloane R; Lyles KW; Goldstein B; Hoenig HM
    Arch Phys Med Rehabil; 2008 Feb; 89(2):237-43. PubMed ID: 18226646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.